Hormetic dose-responses in nanotechnology studies
Ivo Iavicoli1, Luca Fontana1, Veruscka Leso1
1Institute of Public Health, Università Cattolica del Sacro Cuore, Largo Francesco Vito 1, 00168 Roma, Italy.
The Science of the Total Environment
|May 6, 2014
Summary
Nanoparticles may trigger hormetic-like responses in cells, varying with their properties. Further research is needed to understand these dose-response relationships in nanotoxicology, especially at low exposure levels.
Area of Science:
- Nanotoxicology
- Environmental Health
- Biomedical Sciences
Background:
- Growing concern over nanoparticle exposure and limited understanding of human health risks.
- Lack of data on dose-response relationships, particularly at low exposure levels.
- Nanoparticles are increasingly used in various industries, necessitating toxicological assessment.
Purpose of the Study:
- To investigate the occurrence of hormetic-like biphasic dose responses in the nanotoxicology literature.
- To determine if nanoparticle properties influence these dose-response effects.
- To highlight data gaps in understanding nanoparticle toxicology.
Main Methods:
- Systematic review of existing nanotoxicology literature.
- Analysis of studies reporting dose-response relationships for various nanoparticles.
- Assessment of biological cell types and nanoparticle characteristics.
Main Results:
- Evidence suggests nanoparticles can induce hormetic-like biphasic dose responses across diverse cell types.
- Observed responses are significantly influenced by the physical and chemical properties of the nanoparticles.
- The phenomenon appears widespread within the reviewed nanotoxicology studies.
Conclusions:
- Nanoparticles exhibit hormetic-like dose responses, a phenomenon dependent on agent properties.
- Understanding these biphasic responses is crucial for accurate human health risk assessment.
- Further research into the mechanisms of nanoparticle-induced hormesis is a critical data need for the field of nanotoxicology.
Related Concept Videos
Dose Response Curve: Conventional Versus Nonmonotonic
371
The correlation between a drug's dosage and its impact on a biological system is a cornerstone of pharmacology and toxicology. Conventional dose–response curves, which include graded and quantal relationships, are key to this understanding. Graded dose–response curves depict the spectrum of a biological reaction to different doses within an individual, indicating that as the drug dosage increases, so does the intensity of the response. On the other hand, quantal dose–response...
371
Dose-Response Relationship: Overview
5.2K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
5.2K
Drug Toxicity: Dose-Dependent Reactions
229
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
229
Dose-Response Relationship: Potency and Efficacy
6.8K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
6.8K
Toxicity Testing in Animals
204
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
204
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model
155
Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...
155


